United Bank (Virginia)’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,000
| Closed | -$6.03K | – | 143 |
|
|
2024
Q4 | $6.03K | Sell |
12,000
-40,000
| -77% | -$20.1K | ﹤0.01% | 134 |
|
|
2024
Q3 | $47.1K | Hold |
52,000
| – | – | 0.01% | 137 |
|
|
2024
Q2 | $51.9K | Buy |
52,000
+10,000
| +24% | +$9.97K | 0.01% | 136 |
|
|
2024
Q1 | $62.2K | Buy |
42,000
+12,200
| +41% | +$18.1K | 0.01% | 143 |
|
|
2023
Q4 | $32.5K | Hold |
29,800
| – | – | ﹤0.01% | 143 |
|
|
2023
Q3 | $35.2K | Buy |
29,800
+4,200
| +16% | +$4.96K | ﹤0.01% | 142 |
|
|
2023
Q2 | $36.1K | Buy |
+25,600
| New | +$36.1K | ﹤0.01% | 150 |
|